138.53 USD
-4.14 (-2.9%)
138.53 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to ICUI. ICUI was compared to 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ICUI get a neutral evaluation. Nothing too spectacular is happening here. ICUI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
In the past year ICUI had a positive cash flow from operations.
In multiple years ICUI reported negative net income over the last 5 years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
ICUI has a better Return On Assets (-0.18%) than 72.58% of its industry peers.
ICUI has a better Return On Equity (-0.35%) than 73.12% of its industry peers.
The Return On Invested Capital of ICUI (2.86%) is better than 70.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 8.84%.
The last Return On Invested Capital (2.86%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROIC | 2.86% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
The Operating Margin of ICUI (5.63%) is better than 70.43% of its industry peers.
ICUI's Operating Margin has declined in the last couple of years.
ICUI's Gross Margin of 36.47% is on the low side compared to the rest of the industry. ICUI is outperformed by 70.97% of its industry peers.
In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICUI is destroying value.
ICUI has more shares outstanding than it did 1 year ago.
ICUI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ICUI is higher compared to a year ago.
2.2 Solvency
ICUI has an Altman-Z score of 2.19. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.19, ICUI is doing good in the industry, outperforming 63.98% of the companies in the same industry.
ICUI has a debt to FCF ratio of 21.21. This is a negative value and a sign of low solvency as ICUI would need 21.21 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 21.21, ICUI is doing good in the industry, outperforming 69.89% of the companies in the same industry.
A Debt/Equity ratio of 0.62 indicates that ICUI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.62, ICUI is doing worse than 62.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Altman-Z | 2.19 |
ROIC/WACC0.29
WACC9.86%
2.3 Liquidity
ICUI has a Current Ratio of 2.45. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
ICUI has a Current ratio (2.45) which is comparable to the rest of the industry.
ICUI has a Quick Ratio of 1.19. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ICUI (1.19) is worse than 67.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
ICUI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.14%, which is quite impressive.
Measured over the past years, ICUI shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.28% on average per year.
The Revenue has decreased by -0.84% in the past year.
Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
3.2 Future
ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.56% yearly.
The Revenue is expected to grow by 2.95% on average over the next years.
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue Next Year-4.6%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.65%
Revenue Next 5Y2.95%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.40 indicates a rather expensive valuation of ICUI.
Based on the Price/Earnings ratio, ICUI is valued cheaper than 82.26% of the companies in the same industry.
ICUI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.60.
The Price/Forward Earnings ratio is 16.89, which indicates a correct valuation of ICUI.
Based on the Price/Forward Earnings ratio, ICUI is valued cheaper than 83.87% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.23. ICUI is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.4 | ||
| Fwd PE | 16.89 |
4.2 Price Multiples
ICUI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ICUI is cheaper than 83.33% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICUI is valued a bit cheaper than 73.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 54.96 | ||
| EV/EBITDA | 13.62 |
4.3 Compensation for Growth
ICUI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ICUI's earnings are expected to grow with 14.98% in the coming years.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y14.98%
5. Dividend
5.1 Amount
ICUI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
138.53
-4.14 (-2.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners117.94%
Inst Owner Change3.93%
Ins Owners0.96%
Ins Owner Change-1.93%
Market Cap3.42B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (33.57%)
Short Float %5.49%
Short Ratio5.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.14%
Revenue beat(4)3
Avg Revenue beat(4)1.65%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.14%
Revenue beat(8)6
Avg Revenue beat(8)1.04%
Revenue beat(12)6
Avg Revenue beat(12)-0.86%
Revenue beat(16)8
Avg Revenue beat(16)-0.49%
PT rev (1m)0%
PT rev (3m)2.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)8.13%
EPS NY rev (3m)8.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0.98%
Revenue NY rev (3m)0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.4 | ||
| Fwd PE | 16.89 | ||
| P/S | 1.47 | ||
| P/FCF | 54.96 | ||
| P/OCF | 21.45 | ||
| P/B | 1.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.62 |
EPS(TTM)7.96
EY5.75%
EPS(NY)8.2
Fwd EY5.92%
FCF(TTM)2.52
FCFY1.82%
OCF(TTM)6.46
OCFY4.66%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)0.73
PEG (5Y)N/A
Graham Number124.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROCE | 3.62% | ||
| ROIC | 2.86% | ||
| ROICexc | 3.12% | ||
| ROICexgc | 9.01% | ||
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% | ||
| FCFM | 2.68% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 47.91% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.19 |
F-Score7
WACC9.86%
ROIC/WACC0.29
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
Revenue Next Year-4.6%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.65%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y18.75%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
Can you provide the valuation status for ICU MEDICAL INC?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
What is the profitability of ICUI stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
Can you provide the financial health for ICUI stock?
The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 23.92% in the next year.